BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Total investments | 3.89%14.72B | 2.91%14.45B | 2.91%14.45B | 6.23%14.42B | 4.73%14.14B | 4.22%14.17B | 2.92%14.04B | 2.92%14.04B | 0.33%13.57B | 1.50%13.5B |
-Equity investments | -2.88%10.64B | 942.14%10.61B | 942.14%10.61B | 5.06%11.07B | 937.12%10.87B | 986.71%10.95B | 0.79%1.02B | 0.79%1.02B | 957.63%10.53B | 1.85%1.05B |
-Trading assets | 24.56%71M | 33.33%76M | 33.33%76M | 52.94%78M | 71.05%65M | 58.33%57M | 78.13%57M | 78.13%57M | 70.00%51M | 31.03%38M |
-Net loan | 14.54%827M | 23.02%791M | 23.02%791M | 18.79%765M | 19.84%773M | 11.76%722M | -4.88%643M | -4.88%643M | -4.73%644M | -6.79%645M |
-Investments in other ventures under equity method | 25.87%2.33B | 25.52%2.28B | 25.52%2.28B | 5.76%1.91B | 7.18%1.88B | 6.64%1.85B | 6.71%1.81B | 6.71%1.81B | 8.79%1.81B | 8.00%1.76B |
-Short term investments | 53.17%700M | -94.80%540M | -94.80%540M | 11.14%449M | -95.91%404M | -95.45%457M | 2.79%10.38B | 2.79%10.38B | -95.97%404M | 0.94%9.89B |
-Other invested assets | 20.93%156M | 18.60%153M | 18.60%153M | 12.03%149M | 13.95%147M | 1.57%129M | 1.57%129M | 1.57%129M | 1.53%133M | -2.27%129M |
Cash and cash equivalents | 17.39%1.28B | 14.78%1.41B | 14.78%1.41B | 8.27%1.32B | 13.46%1.12B | 26.84%1.09B | 40.48%1.23B | 40.48%1.23B | 53.78%1.22B | 2.17%988M |
Receivables | 4.45%7.39B | 10.00%7.83B | 10.00%7.83B | 16.68%9.2B | 7.14%6.82B | 19.21%7.07B | 14.79%7.12B | 14.79%7.12B | 10.54%7.89B | 7.40%6.37B |
-Accounts receivable | 6.83%6.53B | 12.78%6.71B | 12.78%6.71B | 10.80%7.21B | 7.40%6.07B | 15.46%6.12B | 11.89%5.95B | 11.89%5.95B | 12.11%6.51B | 8.82%5.65B |
-Other receivables | -10.75%855M | -4.10%1.12B | -4.10%1.12B | 44.44%1.99B | 5.13%758M | 50.39%958M | 32.17%1.17B | 32.17%1.17B | 3.69%1.38B | -2.57%721M |
Prepaid assets | 2.50%1.11B | 5.41%1.01B | 5.41%1.01B | 10.06%1.35B | 2.79%1.14B | 5.58%1.08B | 4.80%961M | 4.80%961M | 3.64%1.22B | 10.54%1.11B |
Deferred policy acquisition costs | 2.27%316M | 3.56%320M | 3.56%320M | 4.94%340M | 3.80%328M | 8.42%309M | 7.29%309M | 7.29%309M | 10.96%324M | 7.85%316M |
Goodwill and other intangible assets | 0.00%305M | 0.00%305M | 0.00%305M | 0.00%305M | 23.98%305M | 23.98%305M | 23.98%305M | 23.98%305M | 23.98%305M | 0.00%246M |
-Goodwill | 0.00%305M | 0.00%305M | 0.00%305M | 0.00%305M | 23.98%305M | 23.98%305M | 23.98%305M | 23.98%305M | 23.98%305M | 0.00%246M |
Other assets | -13.31%5.19B | -5.40%5.52B | -5.40%5.52B | -10.09%5.66B | -7.12%6.05B | -8.60%5.98B | -12.54%5.83B | -12.54%5.83B | -1.02%6.29B | 2.76%6.52B |
Total assets | 0.98%30.29B | 3.52%30.84B | 3.52%30.84B | 5.73%32.59B | 2.98%29.91B | 5.34%30B | 3.32%29.79B | 3.32%29.79B | 4.38%30.83B | 3.43%29.05B |
Liabilities | ||||||||||
Policy holders liabilities reserve | -1.11%16.65B | 4.24%21.73B | 4.24%21.73B | 1.72%17.71B | 0.05%17.04B | 0.01%16.84B | 1.43%20.85B | 1.43%20.85B | 2.90%17.41B | 4.75%17.03B |
Payables | 6.94%5.78B | 0.42%1.19B | 0.42%1.19B | 17.84%6.61B | 8.06%5.09B | 19.45%5.41B | 14.59%1.19B | 14.59%1.19B | 5.71%5.61B | 6.12%4.71B |
-Accounts payable | 6.94%5.78B | 0.42%1.19B | 0.42%1.19B | 17.84%6.61B | 8.06%5.09B | 19.45%5.41B | 14.59%1.19B | 14.59%1.19B | 5.71%5.61B | 6.12%4.71B |
Long term debt and capital lease obligation | 0.07%1.48B | 0.00%1.48B | 0.00%1.48B | 0.07%1.48B | 0.07%1.48B | -0.20%1.48B | -1.40%1.48B | -1.40%1.48B | -3.85%1.47B | -4.41%1.47B |
-Long term debt | 0.07%1.48B | 0.00%1.48B | 0.00%1.48B | 0.07%1.48B | 0.07%1.48B | -0.20%1.48B | -1.40%1.48B | -1.40%1.48B | -3.85%1.47B | -4.41%1.47B |
Other liabilities | -2.35%1.99B | -2.32%1.98B | -2.32%1.98B | -11.12%2.09B | 4.63%1.92B | 20.21%2.04B | 19.28%2.02B | 19.28%2.02B | 27.56%2.36B | 3.44%1.83B |
Total liabilities | 0.55%25.9B | 3.29%26.37B | 3.29%26.37B | 3.87%27.88B | 1.89%25.53B | 4.98%25.76B | 3.03%25.53B | 3.03%25.53B | 4.86%26.84B | 4.32%25.06B |
Shareholders'equity | ||||||||||
Share capital | 0.00%84M | 0.00%84M | 0.00%84M | 0.00%84M | -1.18%84M | -1.18%84M | -1.18%84M | -1.18%84M | -1.18%84M | 0.00%85M |
-common stock | 0.00%84M | 0.00%84M | 0.00%84M | 0.00%84M | -1.18%84M | -1.18%84M | -1.18%84M | -1.18%84M | -1.18%84M | 0.00%85M |
Paid-in capital | 1.95%1.41B | 2.84%1.41B | 2.84%1.41B | 2.04%1.4B | 1.09%1.39B | 0.58%1.38B | 0.29%1.37B | 0.29%1.37B | 1.03%1.37B | 1.92%1.38B |
Retained earnings | -0.36%3.08B | 2.88%3.21B | 2.88%3.21B | 8.56%3.36B | 6.48%3.24B | 5.32%3.09B | -0.67%3.12B | -0.67%3.12B | 0.13%3.1B | 2.11%3.04B |
Gains losses not affecting retained earnings | 43.17%-179M | 24.76%-240M | 24.76%-240M | 76.14%-136M | 35.23%-331M | 30.16%-315M | 41.25%-319M | 41.25%-319M | 5.32%-570M | -46.84%-511M |
Total stockholders'equity | 3.58%4.39B | 4.88%4.47B | 4.88%4.47B | 18.26%4.71B | 9.79%4.38B | 7.59%4.24B | 5.08%4.26B | 5.08%4.26B | 1.25%3.98B | -1.82%3.99B |
Total equity | 3.58%4.39B | 4.88%4.47B | 4.88%4.47B | 18.26%4.71B | 9.79%4.38B | 7.59%4.24B | 5.08%4.26B | 5.08%4.26B | 1.25%3.98B | -1.82%3.99B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |